Knowledge Hubs
AI in Medicine
Disparities in Breast Cancer
Alzheimer’s Disease
Sickle Cell
Disparities In HIV
COVID-19 Knowledge Hub
Disparities in Multiple Myeloma
Urban Health Precision Medicine in Prostate Cancer
Conferences
Best of ASH Conference Coverage
Best of ASCO 21 – Hematology
Videos
Podcast
Career Center
About Us
Visit DocWire
Search
Docwire News
Knowledge Hubs
AI in Medicine
Disparities in Breast Cancer
Alzheimer’s Disease
Sickle Cell
Disparities In HIV
COVID-19 Knowledge Hub
Disparities in Multiple Myeloma
Urban Health Precision Medicine in Prostate Cancer
Conferences
Best of ASH Conference Coverage
Best of ASCO 21 – Hematology
Videos
Podcast
Career Center
About Us
Visit DocWire
Home
Urban Health Today
Conference Coverage
Conference Coverage
Evaluating Pirtobrutinib in Patients with Previously Treated Mantle Cell Lymphoma
December 28, 2021
Evaluating Fixed-Duration Ibrutinib and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia
December 28, 2021
Rituximab, Bendamustine, and Bortezomib Combination Improves Responses in Relapsed/Refractory Waldenström Macroglobulinemia
December 28, 2021
Belantamab Mafodotin Shows ‘Encouraging Results’ in Patients with Relapsed/Refractory Multiple Myeloma
December 28, 2021
Orelabrutinib Shows Favorable Safety and Efficacy in Relapsed/Refractory Waldenström Macroglobulinemia
December 23, 2021
GLOW: MRD Outcomes After Fixed-Duration Ibrutinib Combinations in Older CLL Patients
December 23, 2021
iStopMM: Screening for MGUS Enables Earlier Detection and Intervention
December 23, 2021
Long-Term Follow-up From GRIFFIN Confirms Durability of Daratumumab Responses in Transplant-Eligible Myeloma
December 23, 2021
Study Validates IMWG Frailty Scoring in Relapsed/Refractory Multiple Myeloma
December 20, 2021
Ibrutinib Plus FCR Could Provide Functional Cure in Young CLL Patients
December 20, 2021
Load more
Subscribe to RSS